Pharmacology

Action Mechanism of Action Reference
AGONIST Interferon alpha/beta receptor agonist PubMed DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Multiple Sclerosis, Relapsing-Remitting 3 D020529 ClinicalTrials
HIV Infections 3 D015658 ClinicalTrials
Cardiomyopathies 2 D009202 ClinicalTrials
Coronavirus Infections 2 D018352 ClinicalTrials
Severe Acute Respiratory Syndrome 2 D045169 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
23.89
Nervous system disorders
14.42
Injury, poisoning and procedural complications
13.94
Skin and subcutaneous tissue disorders
8.64
Musculoskeletal and connective tissue disorders
7.07
Vascular disorders
4.63
Psychiatric disorders
4.44
Gastrointestinal disorders
3.02
Respiratory, thoracic and mediastinal disorders
2.65
Infections and infestations
2.56
Cardiac disorders
2.36
Immune system disorders
2.21
Investigations
2.18

Cross References

Resources Reference
CAS NUMBER 145155-23-3
ChEMBL CHEMBL1201563
FDA SRS TTD90R31WZ